Alerts will be sent to your verified email
Verify EmailFABINO
|
Fabino Enterprises
|
Kobo Biotech
|
Hemo Organic
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.86 % | -1.77 % | -361.35 % |
|
5yr average Equity Multiplier
|
3.04 | 4.06 | -1.56 |
|
5yr Average Asset Turnover Ratio
|
1.02 | 0.54 | 0.14 |
|
5yr Avg Net Profit Margin
|
0.28 % | -3.79 % | -763.22 % |
|
Price to Book
|
1.19 | 0.0 | 0.0 |
|
P/E
|
79.18 | 0.0 | 40.97 |
|
5yr Avg Cash Conversion Cycle
|
61.26 Days | 0.0 | 100.48 Days |
|
Inventory Days
|
58.83 Days | 89.28 Days | 406.93 Days |
|
Days Receivable
|
271.0 Days | 0.0 | 196.55 Days |
|
Days Payable
|
124.87 Days | 147.48 Days | 2776.86 Days |
|
5yr Average Interest Coverage Ratio
|
2.22 | 0.99 | -250.54 |
|
5yr Avg ROCE
|
2.5 % | 11.79 % | 37.52 % |
|
5yr Avg Operating Profit Margin
|
0.74 % | 8.83 % | -745.72 % |
|
5 yr average Debt to Equity
|
0.28 | 1.62 | -0.73 |
|
5yr CAGR Net Profit
|
43.1 % | n/a | n/a |
|
5yr Average Return on Assets
|
0.27 % | -0.89 % | -33.34 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
56.82 % | 44.95 % | 16.85 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Fabino Enterprises
|
Kobo Biotech
|
Hemo Organic
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|